期刊文献+

大肠癌患者门静脉血CK20mRNA检测的临床意义 被引量:6

Clinical significance of CK20mRNA expression in portal-vein blood of colorectal cancer
下载PDF
导出
摘要 目的:检测大肠癌患者门静脉血CK 20mRNA的表达情况,探讨其临床意义。方法:用实时定量荧光逆转录聚合酶链(FQ-PCR)方法,检测72例大肠癌患者门静脉及周围静脉血CK 20mRNA的表达情况。结果:大肠癌患者门静脉血CK 20mRNA表达的阳性率(72%)高于周围静脉血(43%)(P<0.01),大肠癌Dukes C,D期门静脉血CK 20mRNA高于A,B期(P<0.01)。结论:门静脉血CK 20mRNA表达的检测比周围静脉血检测更准确、敏感,是判断体内隐性播散的可靠方法。 Objective To evaluate the clinical significance of CK20 mRNA expression in portalvein blood of eoloreetal cancer. Methods Expression of CK20mRNA was detected with FQ-PCR in portal-vein blood and peripheral blood in 72 eoloreetal patients. Results The expression of CK20mRNA in portal-vein blood was significantly higher than that in the peripheral blood in every stage of eoloreetal cancer patients. Conclusion The determination of CK20mRNA in portal-vein blood is more accurate and sensitive than in the peripheral vein blood. And it is an ideal means for evaluation of the prognosis.
出处 《实用诊断与治疗杂志》 2007年第1期1-2,共2页 Journal of Practical Diagnosis and Therapy
基金 深圳市科技计划项目(编号200603064)
关键词 大肠癌 微转移 CK20MRNA FQ—PCR Coloreetal cancer mierometastasis CK20mRNA FQ-PCR
  • 相关文献

参考文献5

二级参考文献35

  • 1占强,严洁,蒋志阳,司进,陈涛,郭继中,陶国清.粪便p53基因突变检测在结直肠癌诊断中的应用[J].中华内科杂志,2004,43(7):502-505. 被引量:12
  • 2刘福坤,黎介寿,臧静,赵增顺,祁晓平.胃癌患者骨髓转移癌细胞的检测和临床观察[J].中华外科杂志,1995,33(9):554-556. 被引量:11
  • 3Fearon E R,Vogelstein B.A genetic model for colorectal tumorigenesis[J].Cell,1990,61(5):759
  • 4Kronberg O,Fenger C,Olsen J,et al.Randomised study of screening for colorectal cancer with faecal occult blood test[J].Lancet,1996,348:1467
  • 5Jouve J L,Remontet L,Dancourt V,et al..Estimation of screening test (Hemoccult) sensitivity in colorectal cancer mass screening[J].Br J Cancer,2001,84(11):1477
  • 6Kristinsson J,Nygaard K,Aadland E,et al.Screening of first degree relatives of patients operated for colorectal cancer:evaluation of fecal calprotectin vs.hemoccult II[J].Digestion,2001,64(2):104
  • 7Brandtzaeg P,Gabrielsen T O,Dale I,et al.The leucocyte protein L1 (calprotectin):a putative nonspecific defence factor at epithelial surfaces[J].Adv Exp Med Biol,1995,371A:201
  • 8Tibble J,Sigthorsson G,Foster R,et al.Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma[J].Gut,2001,49(3):402
  • 9Limburg P J,Ahlquist D,Gilbert J,et al.Immunodiscrimination of colorectal neoplasia using MUC1 antibodies:discrepant findings in tissue versus stool[J].Dig Dis Sci,2000,45(3):494
  • 10Yamao T,Matsumura Y,Shimada Y,et al.Abnormal expression of CD44 variants in the exfoliated cells in the feces of patients with colorectal cancer[J].Gastroenterology,1998,114(6):1196

共引文献17

同被引文献57

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部